Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

Caitlin E. Cox

December 14, 2023

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Caitlin E. Cox

November 12, 2023

Presentation TCT 2023

TCT 742: The Association of Incidentally Found Coronary Artery Disease and Empiric Revascularization on Post Operative Myocardial Infarction, Stroke and Death in Patients Undergoing Liver Transplantation

Presenter: Goyal Umadat

October 24, 2023

Presentation TCT 2023

TCT 685: Underlying Atrial Septal Defect in Lung and Liver Transplantation: Mortality and Stroke Risk

Presenter: Bilal Hussain

October 24, 2023

News Daily News

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

L.A. McKeown

September 20, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Caitlin E. Cox

July 06, 2023

News Daily News

Grocery Carts a Tool for AF Screening? An Early Look

Caitlin E. Cox

June 27, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Conference News ESC Heart Failure 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Shelley Wood

May 25, 2023

News Conference News EuroPCR 2023

Renal Denervation: Exploring Its Potential Beyond Hypertension

Todd Neale

May 18, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

TCT 742: The Association of Incidentally Found Coronary Artery Disease and Empiric Revascularization on Post Operative Myocardial Infarction, Stroke and Death in Patients Undergoing Liver Transplantation

TCT 685: Underlying Atrial Septal Defect in Lung and Liver Transplantation: Mortality and Stroke Risk

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Grocery Carts a Tool for AF Screening? An Early Look

FDA Approves Colchicine for Decreasing CV Events

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Renal Denervation: Exploring Its Potential Beyond Hypertension

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content